TransCode Therapeutics Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNAZ TransCode Therapeutics Inc.

提前休市 12-24 13:00:00 EST

7.43

-0.10

-1.33%

盘后7.43

+0.000.00%

15:48 EST

最高7.67	最低7.14	成交量5,596
今开7.15	昨收7.53	日振幅7.04%
总市值681.31万	流通市值618.47万	总股本91.70万
成交额4.14万	换手率0.67%	流通股本83.24万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNAZ","market":"US","secType":"STK","nameCN":"TransCode Therapeutics  Inc.","latestPrice":7.43,"timestamp":1766599200000,"preClose":7.53,"halted":0,"volume":5596,"hourTrading":{"tag":"盘后","latestPrice":7.43,"preClose":7.43,"latestTime":"15:48 EST","volume":137,"amount":1017.46,"timestamp":1766609289304},"delay":0,"floatShares":832400,"shares":916968,"eps":-94.05364,"marketStatus":"提前休市","change":-0.1,"latestTime":"12-24 13:00:00 EST","open":7.15,"high":7.67,"low":7.14,"amount":41425.050328,"amplitude":0.070385,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-94.05364,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766739600000},"marketStatusCode":6,"adr":0,"listingDate":1622520000000,"exchange":"NASDAQ","adjPreClose":7.53,"preHourTrading":{"tag":"盘前","latestPrice":7.53,"preClose":7.56,"latestTime":"09:22 EST","volume":83,"amount":612.6150071000001,"timestamp":1766586154442},"postHourTrading":{"tag":"盘后","latestPrice":7.43,"preClose":7.43,"latestTime":"15:48 EST","volume":137,"amount":1017.46,"timestamp":1766609289304},"volumeRatio":0.650634},"requestUrl":"/m/hq/s/RNAZ","defaultTab":"news","newsList":[{"id":"2592194636","title":"Transcode Therapeutics, Inc.盘中异动 下午盘股价大涨5.29%报8.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592194636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592194636?lang=zh_cn&edition=full","pubTime":"2025-12-20 02:13","pubTimestamp":1766168008,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日02时13分，Transcode Therapeutics, Inc.股票出现波动，股价大幅上涨5.29%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.61%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc是一家生物制药公司，专注于开发和商业化用于癌症治疗和诊断的创新药物和诊断工具。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220021328953b7676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220021328953b7676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNAZ","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"1189260155","title":"TransCode Therapeutics Inc.扩展高管团队，任命米歇尔·贾尼科特博士为高级开发官","url":"https://stock-news.laohu8.com/highlight/detail?id=1189260155","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189260155?lang=zh_cn&edition=full","pubTime":"2025-11-17 21:02","pubTimestamp":1763384540,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc.扩展高管团队，任命米歇尔·贾尼科特博士为高级开发官","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0},{"id":"1163790520","title":"TransCode Therapeutics Inc.完成TTX-MC138治疗转移性疾病的1a期试验——ESMO会议披露相关SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1163790520","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163790520?lang=zh_cn&edition=full","pubTime":"2025-10-14 20:14","pubTimestamp":1760444054,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc.宣布已完成其候选药物TTX-MC138针对转移性疾病的1a期临床试验。该消息通过在欧洲肿瘤内科学会(ESMO)会议上提交的SEC文件得到披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAZ","BK4539"],"gpt_icon":0},{"id":"1168970034","title":"TransCode Therapeutics Inc：Philippe Calais获任首席执行官并继续担任董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=1168970034","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168970034?lang=zh_cn&edition=full","pubTime":"2025-10-08 20:06","pubTimestamp":1759925183,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc宣布，Philippe Calais已被任命为公司首席执行官，同时继续担任董事长职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0},{"id":"1161196722","title":"TransCode Therapeutics Inc.获得CK Life Sciences 2500万美元股权投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1161196722","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161196722?lang=zh_cn&edition=full","pubTime":"2025-10-08 20:05","pubTimestamp":1759925157,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc.宣布，CK Life Sciences将对该公司进行2500万美元的股权投资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"gpt_icon":0},{"id":"1104182027","title":"TransCode Therapeutics (Rnaz)宣布收购Polynoma并获得CK Life Sciences子公司2500万美元战略融资，打造首创独特免疫肿瘤学和转移预防肿瘤学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1104182027","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104182027?lang=zh_cn&edition=full","pubTime":"2025-10-08 20:05","pubTimestamp":1759925143,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (Rnaz)宣布收购Polynoma并获得CK Life Sciences子公司2500万美元战略融资，旨在组建一家首创的独特免疫肿瘤学和转移预防肿瘤学公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"gpt_icon":0},{"id":"2558262506","title":"Transcode Therapeutics, Inc.8月8日成交额为18.37万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558262506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558262506?lang=zh_cn&edition=full","pubTime":"2025-08-09 13:52","pubTimestamp":1754718763,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Transcode Therapeutics, Inc.成交额为18.37万美元，成交额较昨日减少34.73%，当日成交量为1.74万股。Transcode Therapeutics, Inc.于2025年8月8日跌2.44%，报10.39美元，该股过去5个交易日跌9.65%，年初至今跌88.99%，过去60日涨6.94%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809135247a6dc2838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809135247a6dc2838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2557905510","title":"Transcode Therapeutics, Inc.8月7日成交额为28.15万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557905510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557905510?lang=zh_cn&edition=full","pubTime":"2025-08-08 13:50","pubTimestamp":1754632203,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Transcode Therapeutics, Inc.成交额为28.15万美元，成交额较昨日增加22.44%，当日成交量为2.63万股。Transcode Therapeutics, Inc.于2025年8月7日跌4.14%，报10.65美元，该股过去5个交易日跌4.05%，年初至今跌88.71%，过去60日涨6.54%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808135007a6da4c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808135007a6da4c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","RNAZ"],"gpt_icon":0},{"id":"2557536679","title":"Transcode Therapeutics, Inc.8月6日成交额为22.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557536679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557536679?lang=zh_cn&edition=full","pubTime":"2025-08-07 13:44","pubTimestamp":1754545499,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Transcode Therapeutics, Inc.成交额为22.99万美元，成交额较昨日增加15.18%，当日成交量为2.05万股。Transcode Therapeutics, Inc.于2025年8月6日跌3.39%，报11.11美元，该股过去5个交易日跌0.36%，年初至今跌88.23%，过去60日涨16.02%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807134506a47a2de6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807134506a47a2de6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","BK4007","RNAZ"],"gpt_icon":0},{"id":"2557887357","title":"Transcode Therapeutics, Inc.8月4日成交额为47.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557887357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557887357?lang=zh_cn&edition=full","pubTime":"2025-08-05 13:37","pubTimestamp":1754372260,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Transcode Therapeutics, Inc.成交额为47.26万美元，成交额较昨日增加13.24%，当日成交量为4.22万股。Transcode Therapeutics, Inc.于2025年8月4日跌0.87%，报11.4美元，该股过去5个交易日跌17.93%，年初至今跌87.92%，过去60日涨14.69%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805133744a475dc0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805133744a475dc0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNAZ","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2556727861","title":"Transcode Therapeutics, Inc.7月31日成交额为15.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556727861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556727861?lang=zh_cn&edition=full","pubTime":"2025-08-01 13:46","pubTimestamp":1754027187,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Transcode Therapeutics, Inc.成交额为15.78万美元，成交额较昨日减少47.30%，当日成交量为1.42万股。Transcode Therapeutics, Inc.于2025年7月31日跌0.45%，报11.1美元，该股过去5个交易日涨0.91%，年初至今跌88.24%，过去60日跌6.28%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801134631a46f0422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801134631a46f0422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RNAZ","BK4539","LENZ"],"gpt_icon":0},{"id":"2555097631","title":"Transcode Therapeutics, Inc.7月29日成交额为100.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555097631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555097631?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:51","pubTimestamp":1753854707,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Transcode Therapeutics, Inc.成交额为100.35万美元，成交额较昨日减少62.83%，当日成交量为8.01万股。Transcode Therapeutics, Inc.于2025年7月29日跌15.33%，报11.76美元，该股过去5个交易日涨24.58%，年初至今跌87.54%，过去60日跌25.53%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730135149a6c90fa5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730135149a6c90fa5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2554715809","title":"Transcode Therapeutics, Inc.7月25日成交额为72.96万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554715809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554715809?lang=zh_cn&edition=full","pubTime":"2025-07-26 13:43","pubTimestamp":1753508614,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Transcode Therapeutics, Inc.成交额为72.96万美元，成交额较昨日减少57.89%，当日成交量为6.62万股。Transcode Therapeutics, Inc.于2025年7月25日涨6.73%，报11.74美元，该股过去5个交易日涨18.11%，年初至今跌87.56%，过去60日跌2.94%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726134339a4645827&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726134339a4645827&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RNAZ","BK4539","LENZ"],"gpt_icon":0},{"id":"2554569317","title":"Transcode Therapeutics, Inc.7月24日成交额为173.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554569317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554569317?lang=zh_cn&edition=full","pubTime":"2025-07-25 13:33","pubTimestamp":1753421581,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，Transcode Therapeutics, Inc.成交额为173.26万美元，成交额较昨日减少97.16%，当日成交量为15.07万股。Transcode Therapeutics, Inc.于2025年7月24日跌2.4%，报11.0美元，该股过去5个交易日涨9.45%，年初至今跌88.34%，过去60日跌6.91%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725133304a4629bf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725133304a4629bf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","BK4539","RNAZ"],"gpt_icon":0},{"id":"2553767522","title":"Transcode Therapeutics, Inc.7月23日成交额为6098.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553767522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553767522?lang=zh_cn&edition=full","pubTime":"2025-07-24 13:29","pubTimestamp":1753334943,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Transcode Therapeutics, Inc.成交额为6098.48万美元，成交额较昨日增加25514.84%，当日成交量为416.81万股。Transcode Therapeutics, Inc.于2025年7月23日涨19.39%，报11.27美元，该股过去5个交易日涨20.15%，年初至今跌88.06%，过去60日涨5.92%。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724132907a6beee38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724132907a6beee38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RNAZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2518275610","title":"Transcode Therapeutics, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275610?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613493,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Transcode Therapeutics, Inc.股票出现波动，股价快速拉升5.10%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1825.42%、384.06%、45.95%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、Y-Mabs Therapeutics, Inc.，振幅分别为99.13%、98.72%、94.67%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213133964035b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213133964035b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNAZ","LENZ","BK4539"],"gpt_icon":0},{"id":"2516823632","title":"Transcode Therapeutics, Inc.盘中异动 早盘快速跳水5.05%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516823632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516823632?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:34","pubTimestamp":1741012489,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分，Transcode Therapeutics, Inc.股票出现异动，股价快速跳水5.05%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.12%、30.13%、28.75%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.，振幅分别为21.22%、19.25%、15.49%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223450abe63461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223450abe63461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNAZ","LENZ","BK4139"],"gpt_icon":0},{"id":"2514378305","title":"Transcode Therapeutics, Inc.盘中异动 股价大跌5.56%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378305?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:46","pubTimestamp":1740753964,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时46分，Transcode Therapeutics, Inc.股票出现波动，股价大幅下跌5.56%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.、Immunitybio, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为512.94%、339.48%、276.30%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.，振幅分别为45.32%、31.14%、29.25%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822460496341d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822460496341d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2514738591","title":"Transcode Therapeutics, Inc.盘中异动 早盘快速下挫21.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514738591?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:36","pubTimestamp":1740666978,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时36分，Transcode Therapeutics, Inc.股票出现波动，股价急速下挫21.79%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alector, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为434.17%、92.95%、68.95%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Aurinia Pharmaceuticals Inc，振幅分别为16.59%、15.14%、14.91%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223619abdf6ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223619abdf6ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","RNAZ"],"gpt_icon":0},{"id":"2514013879","title":"Transcode Therapeutics, Inc.盘中异动 股价大跌6.05%报6.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013879?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:58","pubTimestamp":1740495491,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时58分，Transcode Therapeutics, Inc.股票出现波动，股价快速跳水6.05%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Lava Therapeutics N.V.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为978.61%、734.95%、562.63%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为121.95%、46.65%、43.70%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225811a2538d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225811a2538d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","RNAZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transcodetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.173},{"period":"1month","weight":-0.1285},{"period":"3month","weight":-0.2767},{"period":"6month","weight":-0.0828},{"period":"1year","weight":-0.9249},{"period":"ytd","weight":-0.9202}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0439},{"period":"3month","weight":0.0406},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1738}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TransCode Therapeutics, Inc.于2016年1月11日根据特拉华州法律成立。该公司是一家RNA肿瘤学公司，创建的基础是相信通过RNA疗法的智能设计和有效递送可以战胜癌症。基于RNA的疗法对其靶点具有高度选择性，有可能在人类基因组中提供一系列以前无法药物治疗的靶点。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.092315},{"month":2,"riseRate":0.25,"avgChangeRate":-0.2746},{"month":3,"riseRate":0.25,"avgChangeRate":-0.194708},{"month":4,"riseRate":0,"avgChangeRate":-0.10214},{"month":5,"riseRate":0.25,"avgChangeRate":0.214726},{"month":6,"riseRate":0.25,"avgChangeRate":-0.263163},{"month":7,"riseRate":0.5,"avgChangeRate":-0.053703},{"month":8,"riseRate":0.2,"avgChangeRate":-0.126775},{"month":9,"riseRate":0.4,"avgChangeRate":0.103909},{"month":10,"riseRate":0.2,"avgChangeRate":-0.169992},{"month":11,"riseRate":0,"avgChangeRate":-0.238135},{"month":12,"riseRate":0.2,"avgChangeRate":-0.123989}],"exchange":"NASDAQ","name":"TransCode Therapeutics  Inc.","nameEN":"TransCode Therapeutics  Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransCode Therapeutics  Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TransCode Therapeutics  Inc.(RNAZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TransCode Therapeutics  Inc.,RNAZ,TransCode Therapeutics  Inc.股票,TransCode Therapeutics  Inc.股票老虎,TransCode Therapeutics  Inc.股票老虎国际,TransCode Therapeutics  Inc.行情,TransCode Therapeutics  Inc.股票行情,TransCode Therapeutics  Inc.股价,TransCode Therapeutics  Inc.股市,TransCode Therapeutics  Inc.股票价格,TransCode Therapeutics  Inc.股票交易,TransCode Therapeutics  Inc.股票购买,TransCode Therapeutics  Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransCode Therapeutics  Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TransCode Therapeutics  Inc.(RNAZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}